Actionable news
All posts from Actionable news
Actionable news in HALO: Halozyme Therapeutics, Inc.,

Today's Perilous Reversal Stock: Halozyme Therapeutics (HALO)

Trade-Ideas LLC identified Halozyme Therapeutics ( HALO) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Halozyme Therapeutics as such a stock due to the following factors:

  • HALO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $21.2 million.
  • HALO has traded 104,491 shares today.
  • HALO is down 3.3% today.
  • HALO was up 6.6% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in HALO with the Ticky from Trade-Ideas. See the FREE profile for HALO NOW at Trade-Ideas More details on HALO: Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Currently there are 3 analysts that rate Halozyme Therapeutics a buy, 1 analyst rates it a sell, and none rate it a hold. The average volume for Halozyme Therapeutics has been 1.4 million shares per day over the past 30 days. Halozyme has a market cap of $2.0 billion and is part of the...